Inspire Medical Systems, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
58.00
-19.00
-44.00
-41.00
-57.00
-33.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-37.00
-40.00
1.00
-6.00
-10.00
-6.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
130.00
24.00
11.00
-20.00
-53.00
-33.00
Cash Flow from Investing Activities
-113.00
-294.00
-19.00
29.00
86.00
-43.00
Cash Flow from Financing Activities
-52.00
13.00
235.00
14.00
134.00
2.00
Net Cash Inflow / Outflow
-35.00
-256.00
227.00
23.00
167.00
-74.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Inspire Medical Systems, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
58.453
-234.00000000027
292.00
124.98%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-37.71
-87.0000000001004
50.00
56.66%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
130.246
232.000000000268
-102.00
-43.86%
Cash Flow from Investing Activities
-113.122
-412.000000000475
299.00
72.54%
Cash Flow from Financing Activities
-52.393
178.000000000205
-230.00
-129.43%
Net Cash Inflow / Outflow
-35.387
-18.0000000000208
-17.00
-96.59%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.118
-16.0000000000185
16.00
99.26%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 428.32% vs 113.10% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
130.25
24.65
428.32%






